Abstract
in this paper, take 30 enterprises from Shenzhen SME board and the GEM pharmaceutical industry as samples, using empirical methods to study the relationship between the pharmaceutical industry and business performance and debt source structure. The results showed that small and medium-sized pharmaceutical enterprises have a negative impact on business performance, and operating liabilities have a positive impact on business performance; compared with the small service enterprises, performance of small and medium-sized pharmaceutical enterprise is poor, because its operating liabilities rate is relatively low, and the financial leverage is higher. Therefore, when small and medium-sized pharmaceutical enterprise debt financing, financing should be appropriate for financial liabilities, and should strengthen the management of debt financing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
